Peptide questions · Tirzepatide

How long does tirzepatide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Tirzepatide’s onset is days–2 weeks, its peak effect comes at 72+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: SURMOUNT Phase III trials. FDA-approved. Head-to-head with semaglutide showing superior weight loss.

Tirzepatide week by week

The library places six of its research notes on tirzepatide on the days they cover, from day 1 to day 504 and on: 6 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The tirzepatide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Getting your gut acclimatedRandomized trial
Days 29–56 (weeks 5–8)First therapeutic dose — weight dropsRandomized trial
Days 57–112 (weeks 9–16)Dual agonism in full effectRandomized trial
Days 113–168 (weeks 17–24)Max titration reachedRandomized trial
Days 169–504 (weeks 25–72)Weeks 24 to 72: where most people plateauRandomized trial
From day 365 onA maintenance medication, not a courseRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track tirzepatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The tirzepatide timeline’s milestones

The library’s timeline for tirzepatide marks 10 points from week 1 to week 52, backed by clinical trial data overall.

  • Week 1: Dual GIP/GLP-1 activation — appetite suppression often strong early
  • Week 2: Commonly reported: meals ending early, with nausea or tiredness for a day or two after the injection
  • Week 4: First escalation (5mg) — ~3–5% body weight loss
  • Week 8: ~5–7% loss, metabolic improvements accelerating
  • Week 12: ~6–9% loss; commonly reported: food noise quiet, meals ending early
  • Week 16: Commonly reported: very strong appetite suppression
  • Week 20: ~10–13% loss — insulin sensitivity notably improved
  • Week 28: ~13–16% loss, cardiovascular markers improved
  • Week 40: ~15–18% loss; many people are nearing their plateau
  • Week 52: One year — on the way to the trial's 15–21% (by dose) at 72 weeks

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why tirzepatide takes that long

Tirzepatide’s half-life is about 5 days (120 hours), so one dose is about 96.9% cleared after 25 days.

On its schedule (Weekly) the doses overlap, and the level of tirzepatide keeps climbing for about 20–25 days before it levels off, so the first 20–25 days run below the level the later weeks hold.

The notes on tirzepatide follow the trials’ dose steps, 2.5mg, 5mg, 7.5mg and 12.5mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Tirzepatide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, tirzepatide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does tirzepatide take to work?

Tirzepatide’s onset is days–2 weeks, its peak effect comes at 72+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does tirzepatide reach its peak effect?

By the library’s timeline, tirzepatide’s peak effect comes at 72+ weeks, backed by clinical trial data.

How long is tirzepatide usually run?

The library’s timeline gives tirzepatide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use.

What does the library say about the first days on tirzepatide?

Its first note on tirzepatide, for days 1–28 (weeks 1–4), is “Getting your gut acclimated”, resting on randomized trials.

More on tirzepatide

Track it in the app

PepVault for iPhone

Track tirzepatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo